Is Tarsus Pharmaceuticals Inc halal to invest in?

As of July 2026, Tarsus Pharmaceuticals Inc TARS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Tarsus Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Tarsus Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Tarsus Pharmaceuticals Inc?

Muslim investors may consider investing in Tarsus Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Tarsus Pharmaceuticals Inc classified as HALAL?

Musaffa determines the Shariah status of Tarsus Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Tarsus Pharmaceuticals Inc updated?

The Shariah compliance status of Tarsus Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Tarsus Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Tarsus Pharmaceuticals Inc?

You can check the latest Shariah compliance status of Tarsus Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

TARS Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Tarsus Pharmaceuticals Inc is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

Tarsus Pharmaceuticals Inc. Stock Analysis TARS

United States Health Care Mid Cap Report: Q1, 2026

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. The company is headquartered in Irvine, California and currently employs 370 full-time employees. The company went IPO on 2020-10-16. The firm is focused on the development and commercialization of therapeutics, starting with eye care. The Company’s lead product candidate, XDEMVY, is a lotilaner ophthalmic solution that targets and eradicates the root cause of Demodex blepharitis, Demodex mite infestation. The active pharmaceutical ingredient (API) of XDEMVY, lotilaner, paralyzes and eradicates mites and other parasites through the inhibition of parasite-specific gamma-aminobutyric acid-gated chloride channels. The firm is investigating the development of its product candidates to address targeted diseases with high unmet medical needs, which include TP-04, a novel ophthalmic gel formulation of lotilaner for the potential treatment of Ocular Rosacea, and TP-05, a novel investigational oral formulation of lotilaner, for potential Lyme disease prophylaxis and community malaria reduction.

Key Statistics of Tarsus Pharmaceuticals Inc (TARS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$56.31$58.78

Today's Open

$57.25

Volume

1.52M

P/E Ratio (TTM)

52 Week Range

$38.51$85.25

Market Cap

2.91B

Avg. Volume

1.50M

Dividend Yield

Financial Metrics & Statements of Tarsus Pharmaceuticals Inc (TARS)

Super Investors Invested in Tarsus Pharmaceuticals Inc (TARS)

FAQ's for Tarsus Pharmaceuticals Inc (TARS)

As of July 2026, Tarsus Pharmaceuticals Inc TARS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Tarsus Pharmaceuticals Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Tarsus Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Tarsus Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Tarsus Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Tarsus Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.